Ascendis Pharma and Novo Nordisk announced a partnership to develop cardiovascular ... BioNTech lowered its guidance for full ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Unfortunately, Big Government getting it wrong on food, nutrition, and health did not begin with COVID-19 or even the ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

Pharmaceutical executives and public health experts have warned that Robert F Kennedy jnr’s influence over Donald Trump could ...

Importantly, we believe these data are very promising because the response was led by de novo T-cell generation ... of mRNA vaccine candidates against influenza and COVID-19, including combinations.

Novo Nordisk leadership acknowledged reports of mortality and ... SGLT2 inhibitors were linked to a reduced risk of all-cause ...

The rapid development of mRNA vaccines during the COVID-19 pandemic exemplified the complex as well as ... from large ...

Novo Nordisk is paying $55 million upfront to ... a phase 3 trial of its CardiAMP stem cell therapy – paused due to COVID-19 – in patients who have previously suffered from a heart attack ...